Beta Bionics, Inc.

XNASHealth care

Last traded price · USD

$15.50

−8.55%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $16.95
Volume: 42
Day's high: —
Day's low: —

In brief

Beta Bionics, Inc. is a health care company listed on Nasdaq, valued at about $843M.
Its shares closed at $16.95 on 4 Nov 2026, down 39.1% over the past year.
From India you can buy BBNX in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Beta Bionics, Inc. (BBNX) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole BBNX share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade BBNX options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: −9.0% (SPY −1.6%, XLV +13.5%). 3 months: +21.9% (SPY −0.4%, XLV +15.5%). 1 year: −39.1% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BBNX, SPY and XLV · as of 4 Nov 2026
7.4 days to cover short interest
6.9M shares were sold short at the 15 Oct 2026 settlement; covering them would take 7.4 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50-day average, above its 200-day
The 4 Nov 2026 close of $16.95 was 10.3% below its 50-day average ($18.90) and 14.7% above its 200-day average ($14.78). It has closed above the 200-day for 39 sessions, since 11 Sep 2026. The 50-day average crossed above the 200-day on 1 Sep 2026, 45 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
34% of the way up its 52-week range
Closed at $16.95 on 4 Nov 2026: 48.2% below the 52-week high of $32.71 (26 Nov 2025) and 92.6% above the low of $8.80 (10 Apr 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−9.0%

6 months+60.4%

1 year−39.1%

5 years—

Newswire

About

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Website

Notable moves

January 9, 2026
−37.04%
May 7, 2025
+26.61%
April 9, 2025
+21.63%

Beta Bionics, Inc.

XNASHealth care

Last traded price · USD

$15.50

−8.55%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $16.95
Volume: 42
Day's high: —
Day's low: —

In brief

Beta Bionics, Inc. is a health care company listed on Nasdaq, valued at about $843M.
Its shares closed at $16.95 on 4 Nov 2026, down 39.1% over the past year.
From India you can buy BBNX in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Beta Bionics, Inc. (BBNX) shares from India?

Do I need the price of a whole BBNX share to invest?

How much can I invest in US stocks in a year?

Can I trade BBNX options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: −9.0% (SPY −1.6%, XLV +13.5%). 3 months: +21.9% (SPY −0.4%, XLV +15.5%). 1 year: −39.1% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BBNX, SPY and XLV · as of 4 Nov 2026
7.4 days to cover short interest
6.9M shares were sold short at the 15 Oct 2026 settlement; covering them would take 7.4 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50-day average, above its 200-day
The 4 Nov 2026 close of $16.95 was 10.3% below its 50-day average ($18.90) and 14.7% above its 200-day average ($14.78). It has closed above the 200-day for 39 sessions, since 11 Sep 2026. The 50-day average crossed above the 200-day on 1 Sep 2026, 45 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
34% of the way up its 52-week range
Closed at $16.95 on 4 Nov 2026: 48.2% below the 52-week high of $32.71 (26 Nov 2025) and 92.6% above the low of $8.80 (10 Apr 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−9.0%

6 months+60.4%

1 year−39.1%

5 years—

Newswire

About

Website

Notable moves

January 9, 2026
−37.04%
May 7, 2025
+26.61%
April 9, 2025
+21.63%

Beta Bionics, Inc.

Beta Bionics, Inc. in brief

Behind SPY and its sector fund XLV over 1 year

7.4 days to cover short interest

Below its 50-day average, above its 200-day

34% of the way up its 52-week range

Beta Bionics, Inc.

Beta Bionics, Inc. in brief

Behind SPY and its sector fund XLV over 1 year

7.4 days to cover short interest

Below its 50-day average, above its 200-day

34% of the way up its 52-week range